Clinical experiences and case review of angiotensin II receptor blocker-related angioedema in Korea
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Hyunah | - |
dc.contributor.author | Baik, Seo Yeon | - |
dc.contributor.author | Yang, So Jung | - |
dc.contributor.author | Kim, Tong Min | - |
dc.contributor.author | Lee, Seung-Hwan | - |
dc.contributor.author | Cho, Jae Hyoung | - |
dc.contributor.author | Choi, In Young | - |
dc.contributor.author | Kim, Ju Han | - |
dc.contributor.author | Yoon, Kun-Ho | - |
dc.contributor.author | Kim, Hun-Sung | - |
dc.date.available | 2021-02-22T06:46:12Z | - |
dc.date.issued | 2019-01 | - |
dc.identifier.issn | 1742-7835 | - |
dc.identifier.issn | 1742-7843 | - |
dc.identifier.uri | https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/3861 | - |
dc.description.abstract | Although angiotensin-converting enzyme inhibitor-related angioedema is well known, angiotensin II receptor blocker (ARB)-related angioedema has not been extensively studied because of its lower incidence. Therefore, ARB-related angioedema is likely to be overlooked in the clinical setting. We analysed the medical records of adults who had been prescribed ARB and diagnosed with angioedema between 2009 and 2015. All adults over the age of 18 years who were initially administered ARB between 1 January 2009 and 31 December 2015 were selected as participants in this study. To confirm whether the angioedema was actually due to the administration of ARB, we conducted a chart review. A total of 35 584 patients were prescribed ARB for the first time when visiting the Seoul St. Mary's Hospital during the study period. Twenty-four patients diagnosed with angioedema for other reasons prior to their first prescription of ARB were excluded from this study. ARB-related angioedema was suspected in six of 35 560 patients (0.02%) who were initially prescribed ARB during the study period. The manifestation of ARB-related angioedema ranged from several days (1/6 case) to several years (3/6 cases). Some patients continued taking ARB with intermittent antihistamine or steroid therapy. In such cases, angioedema symptoms improved but did not completely resolve. Its diagnosis can be delayed and the symptoms may be recurrent as symptoms improve with antihistamine use. In some cases, the same person had different reactions depending on the type of ARB. Definitively diagnosing ARB-related angioedema is difficult, and physicians often overlook angioedema without suspecting that it is an adverse effect of ARB. Close attention of physicians and improved patient education can reduce the incidence of ARB-related angioedema. | - |
dc.format.extent | 8 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | WILEY | - |
dc.title | Clinical experiences and case review of angiotensin II receptor blocker-related angioedema in Korea | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1111/bcpt.13097 | - |
dc.identifier.scopusid | 2-s2.0-85052692134 | - |
dc.identifier.wosid | 000454711300013 | - |
dc.identifier.bibliographicCitation | BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, v.124, no.1, pp 115 - 122 | - |
dc.citation.title | BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | - |
dc.citation.volume | 124 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 115 | - |
dc.citation.endPage | 122 | - |
dc.type.docType | Review | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Toxicology | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Toxicology | - |
dc.subject.keywordPlus | CONVERTING ENZYME-INHIBITOR | - |
dc.subject.keywordPlus | TELMISARTAN | - |
dc.subject.keywordPlus | ANTAGONISTS | - |
dc.subject.keywordPlus | MORTALITY | - |
dc.subject.keywordPlus | RISK | - |
dc.subject.keywordAuthor | adverse event | - |
dc.subject.keywordAuthor | angioedema | - |
dc.subject.keywordAuthor | angiotensin II receptor blocker | - |
dc.subject.keywordAuthor | angiotensin-converting enzyme inhibitors | - |
dc.subject.keywordAuthor | case review | - |
dc.subject.keywordAuthor | electronic medical record | - |
dc.identifier.url | https://onlinelibrary.wiley.com/doi/full/10.1111/bcpt.13097 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Sookmyung Women's University. Cheongpa-ro 47-gil 100 (Cheongpa-dong 2ga), Yongsan-gu, Seoul, 04310, Korea02-710-9127
Copyright©Sookmyung Women's University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.